United States · FDA National Drug Code directory

JOURNAVX

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
51167-548_6af8a930-2a29-428c-96da-94045a1f7d4e
Product NDC
51167-548
Form
TABLET, FILM COATED
Composition / generic term
Suzetrigine
Labeler
Vertex Pharmaceuticals Incorporated
Marketing category
NDA
Marketing start / end (source format)
20250130
Source listing expiry
20271231

Source-listed ingredients

  • SUZETRIGINE — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 5 BLISTER PACK in 1 CARTON (51167-548-25) / 5 TABLET, FILM COATED in 1 BLISTER PACK (51167-548-05) · 51167-548-25
  • 30 TABLET, FILM COATED in 1 BOTTLE (51167-548-30) · 51167-548-30
  • 100 TABLET, FILM COATED in 1 BOTTLE (51167-548-31) · 51167-548-31
  • 10 BLISTER PACK in 1 CARTON (51167-548-34) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 51167-548-34

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →